Latest Ratios: P/E Ratio 11.7x · EV/EBITDA 6.6x · ROE 25.0%. (2001–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $87.0B | $164.4B | $217.5B | $206.8B | $185.4B | $217.4B | $155.4B | $128.9B | $110.8B | $86.4B | $76.8B |
| Enterprise Value | $83.7B | $161.1B | $216.6B | $200.9B | $180.9B | $212.7B | $150.5B | $122.7B | $105.8B | $82.3B | $71.9B |
| P/E Ratio → | 11.70 | 21.40 | 29.89 | 30.06 | 26.93 | 36.74 | 30.41 | 26.96 | 27.27 | 24.04 | 17.83 |
| P/S Ratio | 1.25 | 2.36 | 3.35 | 3.22 | 3.01 | 4.30 | 3.51 | 2.98 | 2.70 | 2.39 | 2.21 |
| P/B Ratio | 2.79 | 5.10 | 7.46 | 7.81 | 8.15 | 10.82 | 8.88 | 8.69 | 10.33 | 8.89 | 9.38 |
| P/FCF | 8.00 | 15.12 | 25.24 | 22.98 | 21.02 | 25.89 | 20.41 | 21.38 | 20.49 | 19.38 | 18.83 |
| P/OCF | 7.58 | 14.33 | 23.82 | 21.71 | 19.44 | 24.22 | 18.92 | 19.44 | 18.38 | 17.37 | 16.79 |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | 2.31 | 3.34 | 3.13 | 2.94 | 4.21 | 3.40 | 2.84 | 2.58 | 2.27 | 2.07 |
| EV / EBITDA | 6.61 | 12.72 | 20.29 | 20.35 | 17.39 | 22.36 | 18.16 | 17.05 | 15.49 | 13.73 | 12.98 |
| EV / EBIT | 8.18 | 15.35 | 22.19 | 21.86 | 19.57 | 27.20 | 22.11 | 19.56 | 18.15 | 17.76 | 12.80 |
| EV / FCF | — | 14.82 | 25.14 | 22.33 | 20.50 | 25.34 | 19.76 | 20.36 | 19.56 | 18.46 | 17.63 |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 31.9% | 31.9% | 32.6% | 32.3% | 32.0% | 32.4% | 31.5% | 30.8% | 30.4% | 30.5% | 29.5% |
| Operating Margin | 14.7% | 14.7% | 14.8% | 13.7% | 15.2% | 15.1% | 14.7% | 14.6% | 14.4% | 14.4% | 13.8% |
| Net Profit Margin | 11.0% | 11.0% | 11.2% | 10.7% | 11.2% | 11.7% | 11.5% | 11.1% | 9.9% | 9.5% | 11.8% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 25.0% | 25.0% | 26.1% | 27.9% | 32.1% | 31.4% | 31.6% | 37.4% | 39.7% | 38.5% | 55.4% |
| ROA | 12.7% | 12.7% | 13.6% | 14.0% | 15.2% | 14.7% | 15.3% | 17.6% | 17.2% | 15.9% | 21.2% |
| ROIC | 26.8% | 26.8% | 29.5% | 34.1% | 41.8% | 40.8% | 45.9% | 65.6% | 78.3% | 87.3% | 128.3% |
| ROCE | 24.9% | 24.9% | 27.3% | 28.0% | 32.7% | 29.4% | 30.2% | 38.2% | 43.4% | 42.2% | 44.9% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.25 | 0.25 | 0.14 | 0.12 | 0.15 | 0.17 | 0.20 | 0.00 | 0.00 | 0.00 | 0.00 |
| Debt / EBITDA | 0.65 | 0.65 | 0.39 | 0.32 | 0.32 | 0.37 | 0.42 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Debt / Equity | — | -0.10 | -0.03 | -0.22 | -0.20 | -0.23 | -0.28 | -0.41 | -0.47 | -0.42 | -0.60 |
| Net Debt / EBITDA | -0.26 | -0.26 | -0.08 | -0.60 | -0.44 | -0.49 | -0.59 | -0.85 | -0.74 | -0.68 | -0.88 |
| Debt / FCF | — | -0.30 | -0.10 | -0.66 | -0.52 | -0.56 | -0.65 | -1.01 | -0.93 | -0.92 | -1.20 |
| Interest Coverage | 45.94 | 45.94 | 165.48 | 193.31 | 195.34 | 131.46 | 205.84 | 273.26 | 298.26 | 297.95 | 345.67 |
Net cash position: cash ($11.5B) exceeds total debt ($8.2B)
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 1.42 | 1.42 | 1.10 | 1.30 | 1.23 | 1.25 | 1.40 | 1.40 | 1.34 | 1.23 | 1.35 |
| Quick Ratio | 1.42 | 1.42 | 1.10 | 1.30 | 1.23 | 1.25 | 1.40 | 1.40 | 1.34 | 1.23 | 1.35 |
| Cash Ratio | 0.56 | 0.56 | 0.26 | 0.50 | 0.45 | 0.52 | 0.67 | 0.55 | 0.50 | 0.42 | 0.55 |
| Asset Turnover | — | 1.07 | 1.16 | 1.25 | 1.30 | 1.17 | 1.20 | 1.45 | 1.68 | 1.59 | 1.69 |
| Inventory Turnover | — | — | — | — | — | — | — | — | — | — | — |
| Days Sales Outstanding | — | 78.50 | 76.86 | 69.61 | 69.79 | 70.27 | 64.61 | 68.37 | 66.75 | 69.47 | 65.27 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 4.1% | 2.3% | 1.5% | 1.4% | 1.3% | 1.0% | 1.3% | 1.4% | 1.5% | 1.8% | 1.9% |
| Payout Ratio | 48.2% | 48.2% | 44.6% | 41.1% | 35.7% | 37.8% | 39.8% | 39.0% | 42.1% | 45.5% | 35.0% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 | FY 2017 | FY 2016 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 8.5% | 4.7% | 3.3% | 3.3% | 3.7% | 2.7% | 3.3% | 3.7% | 3.7% | 4.2% | 5.6% |
| FCF Yield | 12.5% | 6.6% | 4.0% | 4.4% | 4.8% | 3.9% | 4.9% | 4.7% | 4.9% | 5.2% | 5.3% |
| Buyback Yield | 5.3% | 2.8% | 2.1% | 2.1% | 2.2% | 1.7% | 1.9% | 2.1% | 2.4% | 3.1% | 3.4% |
| Total Shareholder Yield | 9.4% | 5.1% | 3.6% | 3.5% | 3.5% | 2.7% | 3.2% | 3.5% | 3.9% | 4.9% | 5.3% |
| Shares Outstanding | — | $632M | $636M | $639M | $643M | $646M | $648M | $650M | $655M | $660M | $668M |
AI-driven billable hour cannibalization
According to current market data, ACN trades at a forward P/E of 9.31, a valuation that appears to discount the firm's historical premium status and suggests investor skepticism regarding the sustainability of double-digit earnings growth in an environment increasingly disrupted by generative AI and shifting enterprise spending.
The current P/E multiple sits significantly below historical averages, implying that the market is pricing in a deceleration of the firm's consulting-led growth engine. This valuation contraction warrants investigation into whether the market views Accenture as a mature, low-growth utility rather than a high-growth technology partner.
Based on reported figures, ACN's ROIC has fluctuated between 5.2% and 8.0% over the last ten quarters, a trend that suggests the firm's aggressive inorganic growth strategy may be diluting the returns generated on its invested capital base compared to more focused, organic-growth-oriented peers.
The volatility in ROIC indicates that the integration of numerous tuck-in acquisitions is not consistently yielding the expected synergies required to drive superior capital returns. Investors should monitor whether the firm can improve its return profile as it shifts focus toward higher-margin, AI-integrated service offerings.
As reported in quarterly financial statements, ACN's DSO has remained elevated, averaging approximately 76 days over the last ten quarters, which highlights the inherent difficulty in managing cash conversion cycles when dealing with large-scale, multi-year enterprise contracts that often involve complex billing and milestone-based payment structures.
The lack of significant improvement in DSO suggests that the firm possesses limited leverage to accelerate cash collection from its 'Diamond Clients.' This persistent working capital drag necessitates a cautious view on the firm's ability to self-fund operations without relying on external financing or cash flow volatility.
Based on the provided balance sheet data, ACN maintains a debt-to-EBITDA ratio of 2.66 as of 2026Q3, a level that appears well within manageable limits and provides the firm with sufficient financial flexibility to continue its acquisition-led growth strategy without jeopardizing its long-term solvency.
The company's interest coverage ratio, while volatile, remains robust, suggesting that debt service obligations are not currently a material risk to the firm's operational stability. However, the reliance on debt to fund acquisitions should be monitored closely if interest rate environments remain elevated for an extended period.
The P/E ratio is frequently misapplied to ACN, as it fails to account for the significant non-cash impact of stock-based compensation and the high volume of acquisition-related amortization that obscures the firm's true underlying cash-generating capacity and operational profitability.
Analysts should instead prioritize P/FCF or EV/EBITDA, as these metrics better reflect the firm's ability to convert service revenue into actual cash flow after accounting for the heavy talent-retention costs inherent in the business model. Relying on P/E alone risks underestimating the true cost of the firm's aggressive human capital and M&A strategy.
Includes 30+ ratios · 25 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying ACN stock.
Accenture plc's current P/E ratio is 11.7x. The historical average is 21.5x.
Accenture plc's current EV/EBITDA is 6.6x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA. The historical average is 12.6x.
Accenture plc's return on equity (ROE) is 25.0%. This is above the typical threshold of 15-20% considered good for most companies. The historical average is 46.1%.
Based on historical data, Accenture plc is trading at a P/E of 11.7x. Compare with industry peers and growth rates for a complete picture.
Accenture plc's current dividend yield is 4.12% with a payout ratio of 48.2%.
Accenture plc has 31.9% gross margin and 14.7% operating margin. Operating margin between 10-20% is typical for established companies.
Accenture plc's Debt/EBITDA ratio is 0.6x, indicating low leverage. A ratio below 2x is generally considered financially healthy.